首页 > 最新文献

Phlebology最新文献

英文 中文
Comparison of staged versus one shot varicose veins treatment: Depending on tributaries diameter. 静脉曲张分期治疗与一次治疗的比较:取决于支流直径。
Pub Date : 2024-08-08 DOI: 10.1177/02683555241272969
Larisa Chernukha, Olexandr Voloshyn, Olexandr Suzdalenko, Viktor Gubka, Serhii Machuskui, Viktor Pavlychenko

Background: One of the most debatable phlebology community's issue is the choice of the optimal tactics for endovenous varicose tributaries correction after truncal ablation. Which tactic will be most effective? There is practically no data concerning treatment tactics' choice for varicose tributary depending on its diameter. Therefore, the comparison of staged versus one-stage treatment of varicose veins is relevant problem in modern phlebology. Research on this topic will make possible determination of advantages and potential disadvantages of the proposed tactics.

Methods: The study included a prospective analysis of the combined treatment of 295 patients with primary varicose veins who underwent outpatient treatment.

Results: Simultaneous EVLA of saphenous trunks and ligation (gentle phlebectomy) of visible large-diameter tributaries (6 mm or more) with staged sclerotherapy after a month, has significant potential benefits.

Conclusion: The use of staged varicose veins treatment minimizes the traumatic intervention and discomfort for the patient, while achieving satisfactory treatment results without affecting the quality of life.

背景:静脉学界最有争议的问题之一,就是选择最佳策略,在截肢消融术后进行静脉内曲张支流矫正。哪种方法最有效?目前几乎没有关于根据曲张支流直径选择治疗策略的数据。因此,静脉曲张分期治疗和一期治疗的比较是现代静脉学的相关问题。对这一课题的研究将有助于确定所建议疗法的优点和潜在缺点:研究对 295 名接受门诊治疗的原发性静脉曲张患者的综合治疗进行了前瞻性分析:结果:同时进行隐静脉主干EVLA和可见大直径支流(6毫米或以上)结扎(轻柔静脉切除术),并在一个月后进行分阶段硬化疗法,具有显著的潜在疗效:结论:分阶段治疗静脉曲张可最大限度地减少创伤性干预和患者的不适感,同时在不影响生活质量的情况下获得满意的治疗效果。
{"title":"Comparison of staged versus one shot varicose veins treatment: Depending on tributaries diameter.","authors":"Larisa Chernukha, Olexandr Voloshyn, Olexandr Suzdalenko, Viktor Gubka, Serhii Machuskui, Viktor Pavlychenko","doi":"10.1177/02683555241272969","DOIUrl":"https://doi.org/10.1177/02683555241272969","url":null,"abstract":"<p><strong>Background: </strong>One of the most debatable phlebology community's issue is the choice of the optimal tactics for endovenous varicose tributaries correction after truncal ablation. Which tactic will be most effective? There is practically no data concerning treatment tactics' choice for varicose tributary depending on its diameter. Therefore, the comparison of staged versus one-stage treatment of varicose veins is relevant problem in modern phlebology. Research on this topic will make possible determination of advantages and potential disadvantages of the proposed tactics.</p><p><strong>Methods: </strong>The study included a prospective analysis of the combined treatment of 295 patients with primary varicose veins who underwent outpatient treatment.</p><p><strong>Results: </strong>Simultaneous EVLA of saphenous trunks and ligation (gentle phlebectomy) of visible large-diameter tributaries (6 mm or more) with staged sclerotherapy after a month, has significant potential benefits.</p><p><strong>Conclusion: </strong>The use of staged varicose veins treatment minimizes the traumatic intervention and discomfort for the patient, while achieving satisfactory treatment results without affecting the quality of life.</p>","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"2683555241272969"},"PeriodicalIF":0.0,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141908771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of lower limb telangiectasias with Nd: Yag 1064 nm laser with and without tumescent anesthesia - TTL technique. 使用掺钕钇钕石榴石(Nd: Yag)1064 nm 激光治疗下肢毛细血管扩张症,采用或不采用膨胀麻醉--TTL 技术。
Pub Date : 2024-08-07 DOI: 10.1177/02683555241273133
Julio Cesar Bajerski, Camila Biedler Giordani, Luiza Brum Borges, Juliana Bosso Taniguchi, Elias Arcenio Neto, Rodrigo Kikuchi, Jaber Nashat Saleh, Rafael Stevan Noel, Renan Camargo Puton, Mateus Picada Correa

Introduction: Transdermal laser is an option for varicous veins treatment, yet it may be painful. In this study, we will present a technique for performing tumescent anesthesia associated to transdermal laser (TTL) to reduce pain during treatment.

Objective: The study compares pain during treatment of telangiectasias in lower limb with and without tumescent anesthesia to offer a less painful procedure.

Methods: 50 CEAP C1 patients with bilateral telangiectasias on thighs underwent transdermal laser treatment, using tumescent anesthesia on one side and standard technique on the other. Pain was assessed via the Visual Analogue Scale. The outcomes were compared with Student's t-test. Significance was set at p < .05.

Results: Laser treatment without tumescent anesthesia resulted in a VAS pain score of 7.9, versus 0.0 with anesthesia, showing a significant statistical difference.

Conclusion: Tumescent anesthesia and transdermal laser (TTL) is capable of reducing pain in laser treatment of telangiectasias and reticular veins.

简介透皮激光是治疗静脉曲张的一种选择,但可能会带来疼痛。在本研究中,我们将介绍一种与透皮激光(TTL)相关的膨胀麻醉技术,以减轻治疗过程中的疼痛:方法:50 名患有双侧大腿毛细血管瘤的 CEAP C1 患者接受了透皮激光治疗,一侧使用膨胀麻醉,另一侧使用标准技术。疼痛通过视觉模拟量表进行评估。结果比较采用学生 t 检验。显著性以 p < .05 为标准:结果:未使用膨胀麻醉的激光治疗的 VAS 疼痛评分为 7.9,而使用麻醉的疼痛评分为 0.0,两者之间存在显著的统计学差异:结论:膨胀麻醉和透皮激光(TTL)能够减轻毛细血管扩张和网状静脉激光治疗的疼痛。
{"title":"Treatment of lower limb telangiectasias with Nd: Yag 1064 nm laser with and without tumescent anesthesia - TTL technique.","authors":"Julio Cesar Bajerski, Camila Biedler Giordani, Luiza Brum Borges, Juliana Bosso Taniguchi, Elias Arcenio Neto, Rodrigo Kikuchi, Jaber Nashat Saleh, Rafael Stevan Noel, Renan Camargo Puton, Mateus Picada Correa","doi":"10.1177/02683555241273133","DOIUrl":"https://doi.org/10.1177/02683555241273133","url":null,"abstract":"<p><strong>Introduction: </strong>Transdermal laser is an option for varicous veins treatment, yet it may be painful. In this study, we will present a technique for performing tumescent anesthesia associated to transdermal laser (TTL) to reduce pain during treatment.</p><p><strong>Objective: </strong>The study compares pain during treatment of telangiectasias in lower limb with and without tumescent anesthesia to offer a less painful procedure.</p><p><strong>Methods: </strong>50 CEAP C1 patients with bilateral telangiectasias on thighs underwent transdermal laser treatment, using tumescent anesthesia on one side and standard technique on the other. Pain was assessed via the Visual Analogue Scale. The outcomes were compared with Student's t-test. Significance was set at <i>p</i> < .05.</p><p><strong>Results: </strong>Laser treatment without tumescent anesthesia resulted in a VAS pain score of 7.9, versus 0.0 with anesthesia, showing a significant statistical difference.</p><p><strong>Conclusion: </strong>Tumescent anesthesia and transdermal laser (TTL) is capable of reducing pain in laser treatment of telangiectasias and reticular veins.</p>","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"2683555241273133"},"PeriodicalIF":0.0,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141904047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authors reply: Polymerisation of cyanoacrylates: The effect of sclero-embolic and contrast agents. 作者回复:氰基丙烯酸酯的聚合:硬化剂和造影剂的影响。
Pub Date : 2024-08-04 DOI: 10.1177/02683555241271932
Joseph Gracé, David Connor, Kurosh Parsi
{"title":"Authors reply: Polymerisation of cyanoacrylates: The effect of sclero-embolic and contrast agents.","authors":"Joseph Gracé, David Connor, Kurosh Parsi","doi":"10.1177/02683555241271932","DOIUrl":"https://doi.org/10.1177/02683555241271932","url":null,"abstract":"","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"2683555241271932"},"PeriodicalIF":0.0,"publicationDate":"2024-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141891483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selected phlebological abstracts. 静脉学摘要选编。
Pub Date : 2024-08-01 Epub Date: 2024-07-20 DOI: 10.1177/02683555241265812
Lowell S Kabnick, Kathleen Ozsvath, Jorge H Ulloa
{"title":"Selected phlebological abstracts.","authors":"Lowell S Kabnick, Kathleen Ozsvath, Jorge H Ulloa","doi":"10.1177/02683555241265812","DOIUrl":"10.1177/02683555241265812","url":null,"abstract":"","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"500-502"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141728512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of venous leg ulcers. 静脉性腿部溃疡的治疗。
Pub Date : 2024-08-01 Epub Date: 2024-03-29 DOI: 10.1177/02683555241243167
Matthew Tan, Fedor Lurie, Hernan Bauza Moreno, Daphne Van den Bussche, Kurosh Parsi, Alun H Davies
{"title":"Management of venous leg ulcers.","authors":"Matthew Tan, Fedor Lurie, Hernan Bauza Moreno, Daphne Van den Bussche, Kurosh Parsi, Alun H Davies","doi":"10.1177/02683555241243167","DOIUrl":"10.1177/02683555241243167","url":null,"abstract":"","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"488-491"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11380361/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140327593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cyanoacrylate glue is an effective alternative in chronic venous insufficiency. 氰基丙烯酸酯胶水是治疗慢性静脉功能不全的有效替代品。
Pub Date : 2024-08-01 Epub Date: 2024-03-25 DOI: 10.1177/02683555241239545
Ahmet Kursat Bozkurt
{"title":"Cyanoacrylate glue is an effective alternative in chronic venous insufficiency.","authors":"Ahmet Kursat Bozkurt","doi":"10.1177/02683555241239545","DOIUrl":"10.1177/02683555241239545","url":null,"abstract":"","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"498-499"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140290129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regarding: 899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: The untold story of cyanoacrylate adhesive closure. Parsi K et al. 关于899 例严重不良事件,包括 13 例死亡、7 例中风、211 例血栓栓塞事件和 482 例免疫反应:氰基丙烯酸酯粘合剂闭合术的不为人知的故事。Parsi K 等人
Pub Date : 2024-08-01 Epub Date: 2024-03-15 DOI: 10.1177/02683555241239549
Steve Elias, Nicos Labropoulos, Stephen Black, Antonios Gasparis, Neil Khilnani
{"title":"Regarding: 899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: The untold story of cyanoacrylate adhesive closure. Parsi K et al.","authors":"Steve Elias, Nicos Labropoulos, Stephen Black, Antonios Gasparis, Neil Khilnani","doi":"10.1177/02683555241239549","DOIUrl":"10.1177/02683555241239549","url":null,"abstract":"","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"492-493"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140141297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authors reply: 899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: The untold story of cyanoacrylate adhesive closure. 作者回复:899 例严重不良事件,包括 13 例死亡、7 例中风、211 例血栓栓塞事件和 482 例免疫反应:氰基丙烯酸酯粘合剂闭合术不为人知的故事。
Pub Date : 2024-08-01 Epub Date: 2024-03-25 DOI: 10.1177/02683555241239553
Kurosh Parsi, Joseph Grace, David Connor
{"title":"Authors reply: 899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: The untold story of cyanoacrylate adhesive closure.","authors":"Kurosh Parsi, Joseph Grace, David Connor","doi":"10.1177/02683555241239553","DOIUrl":"10.1177/02683555241239553","url":null,"abstract":"","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"494-496"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140290128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High intensity focused ultrasound in treating great saphenous vein incompetence: Perioperative and 1-year outcomes. 高强度聚焦超声治疗大隐静脉闭塞:围手术期和 1 年疗效
Pub Date : 2024-08-01 Epub Date: 2024-04-01 DOI: 10.1177/02683555241243161
Paolo Casoni, Daniele Bissacco, Matteo Pizzamiglio, Emanuele Nanni

Background: To investigate the use of high intensity focused ultrasound (HIFU) for great saphenous vein (GSV) incompetence.

Material and methods: Patients with GSV incompetence underwent HIFU. The primary endpoint was the rate of GSV target segment shrinkage or closure after 1 year.

Results: Out of 188 limbs treated, the GSV treated segment shrinkage/closure rate at 1 week, 3 months, 6 months, and 12 months was 93.3%, 98.2%, 97.6%, and 98.3%, respectively.

Conclusion: These preliminary results suggest that HIFU holds promise for the treatment of GSV incompetence. Further trials are needed to compare it with other techniques and assess long-term outcomes.

背景:研究高强度聚焦超声(HIFU)治疗大隐静脉(GSV)闭塞:研究高强度聚焦超声(HIFU)在大隐静脉(GSV)闭锁中的应用:材料: GSV闭塞患者接受了HIFU治疗。主要终点是一年后GSV靶段萎缩或闭合率:1周、3个月、6个月和12个月的GSV治疗段收缩/闭合率分别为93.3%、98.2%、97.6%和98.3%:这些初步结果表明,HIFU有望用于治疗GSV闭锁不全。还需要进行更多试验,将其与其他技术进行比较,并评估长期疗效。
{"title":"High intensity focused ultrasound in treating great saphenous vein incompetence: Perioperative and 1-year outcomes.","authors":"Paolo Casoni, Daniele Bissacco, Matteo Pizzamiglio, Emanuele Nanni","doi":"10.1177/02683555241243161","DOIUrl":"10.1177/02683555241243161","url":null,"abstract":"<p><strong>Background: </strong>To investigate the use of high intensity focused ultrasound (HIFU) for great saphenous vein (GSV) incompetence.</p><p><strong>Material and methods: </strong>Patients with GSV incompetence underwent HIFU. The primary endpoint was the rate of GSV target segment shrinkage or closure after 1 year.</p><p><strong>Results: </strong>Out of 188 limbs treated, the GSV treated segment shrinkage/closure rate at 1 week, 3 months, 6 months, and 12 months was 93.3%, 98.2%, 97.6%, and 98.3%, respectively.</p><p><strong>Conclusion: </strong>These preliminary results suggest that HIFU holds promise for the treatment of GSV incompetence. Further trials are needed to compare it with other techniques and assess long-term outcomes.</p>","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"448-455"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140338507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Compression therapy after endovenous laser ablation: Patient compliance and impact on clinical outcome. 静脉腔内激光消融术后的压迫疗法:患者依从性及其对临床结果的影响。
Pub Date : 2024-08-01 Epub Date: 2024-05-07 DOI: 10.1177/02683555241249222
Carmen K Dietrich, Markus Stucker, Karsten Hartmann, Tobias Hirsch, Thomas Mattausch, Hans-Christian Wenzel, Philipp Zollmann, Jürgen Veltman, Thomas K Weiler, Guido Lengfellner, Lars Müller, Felizitas Pannier, Christiane Cussigh, Lorenz Uhlmann, Christine Müller-Christmann

Objectives: This study aimed to investigate the impact of post-interventional compression therapy on clinical outcomes after endovenous laser ablation (EVLA) of incompetent saphenous veins.

Methods: This prospective, controlled, multicenter study in Germany involved 493 varicose vein patients followed-up for 6 months.

Results: Compression therapy significantly reduced symptoms compared to no compression (VCSS: 1.4 ± 1.6 vs 2.2 ± 2.2; p = .007). Post-interventional therapy duration of up to 14 days was found to be most effective for improving patient-reported disease severity (p < .001) and higher quality of life (p = .001). Patient compliance was high (82%), and non-compliance was linked to worse disease severity (VCSS 1.4 ± 1.5 vs 2.1 ± 2.3, p = .009).

Conclusion: In conclusion, post-interventional compression therapy is beneficial by reducing symptoms and improving quality of life. High patient compliance with the therapy is observed, and non-compliance is associated with worse disease severity.

研究目的本研究旨在探讨静脉腔内激光消融术(EVLA)治疗无功能隐静脉后,介入治疗后加压疗法对临床疗效的影响:这项在德国进行的前瞻性、对照、多中心研究对493名静脉曲张患者进行了为期6个月的随访:结果:与不压迫相比,压迫疗法能明显减轻症状(VCSS:1.4 ± 1.6 vs 2.2 ± 2.2;p = .007)。干预治疗后持续长达 14 天的时间对改善患者报告的疾病严重程度(p < .001)和提高生活质量(p = .001)最为有效。患者的依从性很高(82%),不依从与疾病严重程度恶化有关(VCSS 1.4 ± 1.5 vs 2.1 ± 2.3,p = .009):总之,介入治疗后加压疗法可减轻症状,提高生活质量。患者对治疗的依从性很高,不依从与疾病严重程度恶化有关。
{"title":"Compression therapy after endovenous laser ablation: Patient compliance and impact on clinical outcome.","authors":"Carmen K Dietrich, Markus Stucker, Karsten Hartmann, Tobias Hirsch, Thomas Mattausch, Hans-Christian Wenzel, Philipp Zollmann, Jürgen Veltman, Thomas K Weiler, Guido Lengfellner, Lars Müller, Felizitas Pannier, Christiane Cussigh, Lorenz Uhlmann, Christine Müller-Christmann","doi":"10.1177/02683555241249222","DOIUrl":"10.1177/02683555241249222","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to investigate the impact of post-interventional compression therapy on clinical outcomes after endovenous laser ablation (EVLA) of incompetent saphenous veins.</p><p><strong>Methods: </strong>This prospective, controlled, multicenter study in Germany involved 493 varicose vein patients followed-up for 6 months.</p><p><strong>Results: </strong>Compression therapy significantly reduced symptoms compared to no compression (VCSS: 1.4 ± 1.6 vs 2.2 ± 2.2; <i>p</i> = .007). Post-interventional therapy duration of up to 14 days was found to be most effective for improving patient-reported disease severity (<i>p</i> < .001) and higher quality of life (<i>p</i> = .001). Patient compliance was high (82%), and non-compliance was linked to worse disease severity (VCSS 1.4 ± 1.5 vs 2.1 ± 2.3, <i>p</i> = .009).</p><p><strong>Conclusion: </strong>In conclusion, post-interventional compression therapy is beneficial by reducing symptoms and improving quality of life. High patient compliance with the therapy is observed, and non-compliance is associated with worse disease severity.</p>","PeriodicalId":94350,"journal":{"name":"Phlebology","volume":" ","pages":"477-487"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140861561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Phlebology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1